BARBEE CUNNINGHAM: Open Payments
NPI 1891380564 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 21 payments from 7 companies in 2025. Trend: 2023 $1,091 · 2024 $783 · 2025 $1,183
Food & beverage: $1,136Education: $47
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $339 |
| TG Therapeutics, Inc. | 6 | $273 |
| Alexion Pharmaceuticals, Inc. | 3 | $270 |
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| Janssen Biotech, Inc. | 2 | $114 |
| ARGENX US, INC. | 2 | $48 |
| TerSera Therapeutics LLC | 1 | $16 |
Products named: UPLIZNA, BRIUMVI, ULTOMIRIS, TEZSPIRE, VYVGART HYTRULO, VYVGART, Quzyttir, KRYSTEXXA.
Industry payments across TX — which companies pay providers there.
